Global Pharmaceuticals & Biotech Big Green Snowflakes

BIONET Therapeutics

Market Cap: NT$3.9b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

StemCyte International

Market Cap: NT$4.7b

Operates cord blood cell banks in the United States and Taiwan.

XtalPi Holdings

Market Cap: HK$44.0b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

D&D Pharmatech

Market Cap: ₩1.7t

A clinical-stage biotech company, develops medicines in South Korea and the United States.

Nextgen Biomed

Market Cap: ₪7.0m

Develops topical treatment for psoriasis.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥3.1b

Researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally.

Formosa Pharmaceuticals

Market Cap: NT$4.6b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

Tuoxin Pharmaceutical GroupLtd

Market Cap: CN¥4.2b

Engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China.

IMB Dx

Market Cap: ₩141.9b

Provides liquid biopsy platform in South Korea.

Tryptamine Therapeutics

Market Cap: AU$46.1m

A clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States.

Y-Biologics

Market Cap: ₩192.5b

An antibody new drug development platform company, engages in the research and development of immuno-oncology drugs and antibody drugs.

EyeGene

Market Cap: ₩77.6b

Engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea.

Optipharm.CO.LTD

Market Cap: ₩77.0b

Operates as a biomedical solution provider in South Korea.

Anatara Lifesciences

Market Cap: AU$3.0m

Engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia.

BioSenic

Market Cap: €1.8m

A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.

Coretech 5 Société anonyme

Market Cap: €2.6m

A pharmaceutical development company, engages in the development and marketing of various veterinary solutions for pets.

HAVN Life Sciences

Market Cap: CA$859.4k

A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

Celestra

Market Cap: ₩13.5b

A biotechnology company, provides genome-based cancer and disease diagnostic solutions.

Union Korea Pharm

Market Cap: ₩15.4b

Engages in the research, development, production, and sale of prescription drugs in South Korea.

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

FibroBiologics

Market Cap: US$22.5m

Operates as a cell therapy, regenerative medicine company.

Waverley Pharma

Market Cap: CA$810.0k

A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.

Altamira Therapeutics

Market Cap: US$293.2k

Operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe.

BioCardia

Market Cap: US$12.2m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

Avenir Wellness Solutions

Market Cap: US$9.0k

Together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness.

Atlantic International

Market Cap: US$193.2m

Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.

MiNK Therapeutics

Market Cap: US$69.5m

A clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.

Arrowhead Pharmaceuticals

Market Cap: US$3.8b

Develops medicines for the treatment of intractable diseases in the United States.

Actuate Therapeutics

Market Cap: US$176.5m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

Revive Therapeutics

Market Cap: CA$8.6m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Mountain Valley MD Holdings

Market Cap: CA$7.0m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Shinpoong PharmaceuticalLtd

Market Cap: ₩670.8b

Manufactures and sells pharmaceutical products in South Korea.

Organoidsciences

Market Cap: ₩242.2b

Develops regenerative therapies in South Korea.

Sunshine Lake Pharma

Market Cap: HK$25.8b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

TaiRx

Market Cap: NT$2.7b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

Medigen Vaccine Biologics

Market Cap: NT$12.3b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.